>
Former White House Advisor: "Trump to Release $150 Trillion Endowment"
The Mayo Clinic just tried to pull a fast one on the Trump administration...
'Cyborg 1.0': World's First Robocop Debuts With Facial Recognition And 360° Camera Visio
Dr. Aseem Malhotra Joins Alex Jones Live In-Studio! Top Medical Advisor To HHS Sec. RFK Jr. Gives...
Scientists reach pivotal breakthrough in quest for limitless energy:
Kawasaki CORLEO Walks Like a Robot, Rides Like a Bike!
World's Smallest Pacemaker is Made for Newborns, Activated by Light, and Requires No Surgery
Barrel-rotor flying car prototype begins flight testing
Coin-sized nuclear 3V battery with 50-year lifespan enters mass production
BREAKTHROUGH Testing Soon for Starship's Point-to-Point Flights: The Future of Transportation
Molten salt test loop to advance next-gen nuclear reactors
Quantum Teleportation Achieved Over Internet For The First Time
Watch the Jetson Personal Air Vehicle take flight, then order your own
Microneedles extract harmful cells, deliver drugs into chronic wounds
In 2013, GlaxoSmithKline shutdown Sirtris (David Sinclair's company) about five years after spending $720 million to buy Sirtris.
David A. Sinclair, Ph.D., A.O. is a Professor in the Department of Genetics and co-Director of the Paul F. Glenn Center for the Biology of Aging at Harvard Medical School. Dr. Sinclair is co-founder of several biotechnology companies (Sirtris, Ovascience, Genocea, Cohbar, MetroBiotech, ArcBio, Liberty Biosecurity) and is on the boards of several others. He is also co-founder and co-chief editor of the journal Aging.
Life Biosciences was co-founded in 2017 by David A. Sinclair, PhD, AO, a professor in the Department of Genetics at Harvard Medical School, and Tristan Edwards, an investment professional who developed its innovative company structure.